New blood pressure drug shows promise in phase 2 trial
NCT ID NCT05103332
First seen Nov 03, 2025 · Last updated May 15, 2026 · Updated 25 times
Summary
This study tested a new drug called zilebesiran in 663 adults whose high blood pressure was not well controlled by their current medicines. Participants took zilebesiran or a placebo alongside their usual blood pressure pills. The main goal was to see if zilebesiran could lower blood pressure more than placebo over 3 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Trial Site
Mesa, Arizona, 85213, United States
-
Clinical Trial Site
Tempe, Arizona, 85281, United States
-
Clinical Trial Site
Tempe, Arizona, 85282, United States
-
Clinical Trial Site
Bell Gardens, California, 90201, United States
-
Clinical Trial Site
Canoga Park, California, 91304, United States
-
Clinical Trial Site
Carlsbad, California, 92008, United States
-
Clinical Trial Site
Encinitas, California, 92024, United States
-
Clinical Trial Site
Garden Grove, California, 92844, United States
-
Clinical Trial Site
Hollywood, California, 91606, United States
-
Clinical Trial Site
Huntington Beach, California, 92647, United States
-
Clinical Trial Site
Irvine, California, 92614, United States
-
Clinical Trial Site
Long Beach, California, 90805, United States
-
Clinical Trial Site
Los Angeles, California, 90057, United States
-
Clinical Trial Site
Mission Hills, California, 91345, United States
-
Clinical Trial Site
Oceanside, California, 92056, United States
-
Clinical Trial Site
Panorama City, California, 91402, United States
-
Clinical Trial Site
San Diego, California, 92103, United States
-
Clinical Trial Site
Santa Clarita, California, 91355, United States
-
Clinical Trial Site
South Gate, California, 90280, United States
-
Clinical Trial Site
Tustin, California, 92780, United States
-
Clinical Trial Site
Upland, California, 91786, United States
-
Clinical Trial Site
Washington D.C., District of Columbia, 20011, United States
-
Clinical Trial Site
Clearwater, Florida, 33756, United States
-
Clinical Trial Site
Coconut Creek, Florida, 33073, United States
-
Clinical Trial Site
Coral Gables, Florida, 33134, United States
-
Clinical Trial Site
Hollywood, Florida, 33021, United States
-
Clinical Trial Site
Hollywood, Florida, 33024, United States
-
Clinical Trial Site
Inverness, Florida, 34452, United States
-
Clinical Trial Site
Jacksonville, Florida, 32256, United States
-
Clinical Trial Site
Miami, Florida, 33032, United States
-
Clinical Trial Site
Miami, Florida, 33125, United States
-
Clinical Trial Site
Miami, Florida, 33135, United States
-
Clinical Trial Site
Miami, Florida, 33144, United States
-
Clinical Trial Site
Miami, Florida, 33176, United States
-
Clinical Trial Site
Naples, Florida, 34105, United States
-
Clinical Trial Site
Orlando, Florida, 32162, United States
-
Clinical Trial Site
Orlando, Florida, 32801, United States
-
Clinical Trial Site
Pembroke Pines, Florida, 33027, United States
-
Clinical Trial Site
Tampa, Florida, 33603, United States
-
Clinical Trial Site
Winter Haven, Florida, 33880, United States
-
Clinical Trial Site
Winter Park, Florida, 32789, United States
-
Clinical Trial Site
Acworth, Georgia, 30101, United States
-
Clinical Trial Site
Canton, Georgia, 30114, United States
-
Clinical Trial Site
Columbus, Georgia, 31904, United States
-
Clinical Trial Site
Savannah, Georgia, 31406, United States
-
Clinical Trial Site
Louisville, Kentucky, 40202, United States
-
Clinical Trial Site
New Orleans, Louisiana, 70769, United States
-
Clinical Trial Site
Southgate, Michigan, 48195, United States
-
Clinical Trial Site
Jackson, Mississippi, 39209, United States
-
Clinical Trial Site
Hazelwood, Missouri, 63042, United States
-
Clinical Trial Site
Jefferson City, Missouri, 65109, United States
-
Clinical Trial Site
New York, New York, 10036, United States
-
Clinical Trial Site
Greensboro, North Carolina, 27403, United States
-
Clinical Trial Site
Greensboro, North Carolina, 27410, United States
-
Clinical Trial Site
Monroe, North Carolina, 28112, United States
-
Clinical Trial Site
Norman, Oklahoma, 73072, United States
-
Clinical Trial Site
Little River, South Carolina, 29566, United States
-
Clinical Trial Site
Memphis, Tennessee, 38119, United States
-
Clinical Trial Site
Amarillo, Texas, 79109, United States
-
Clinical Trial Site
Coppell, Texas, 75019, United States
-
Clinical Trial Site
Dallas, Texas, 75251, United States
-
Clinical Trial Site
Houston, Texas, 77074, United States
-
Clinical Trial Site
Houston, Texas, 77081, United States
-
Clinical Trial Site
Lake Jackson, Texas, 77566, United States
-
Clinical Trial Site
Plano, Texas, 75024, United States
-
Clinical Trial Site
Sherman, Texas, 75092, United States
-
Clinical Trial Site
Splendora, Texas, 77372, United States
-
Clinical Trial Site
Stephenville, Texas, 76401, United States
-
Clinical Trial Site
Tomball, Texas, 77375, United States
-
Clinical Trial Site
Waco, Texas, 76708, United States
-
Clinical Trial Site
Burke, Virginia, 22015, United States
-
Clinical Trial Site
Kenosha, Wisconsin, 53142, United States
-
Clinical Trial Site
Brampton, Ontario, Canada
-
Clinical Trial Site
Concord, Ontario, Canada
-
Clinical Trial Site
London, Ontario, N5W 6A2, Canada
-
Clinical Trial Site
Toronto, Ontario, Canada
-
Clinical Trial Site
Winnipeg, Ontario, Canada
-
Clinical Trial Site
Chicoutimi, Quebec, Canada
-
Clinical Trial Site
Lévis, Quebec, Canada
-
Clinical Trial Site
Pointe-Claire, Quebec, Canada
-
Clinical Trial Site
Québec, Quebec, Canada
-
Clinical Trial Site
Sherbrooke, Quebec, Canada
-
Clinical Trial Site
Trois-Rivières, Quebec, Canada
-
Clinical Trial Site
Québec, Canada
-
Clinical Trial Site
Tartu, Estonia
-
Clinical Trial Site
Frankfurt, Germany
-
Clinical Trial Site
Riga, Latvia
-
Clinical Trial Site
Kaunas, Lithuania
-
Clinical Trial Site
Vilnius, Lithuania
-
Clinical Trial Site
Częstochowa, Poland
-
Clinical Trial Site
Gdansk, Poland
-
Clinical Trial Site
Katowice, Poland
-
Clinical Trial Site
Staszów, Poland
-
Clinical Trial Site
Warsaw, Poland
-
Clinical Trial Site
Wroclaw, Poland
-
Clinical Trial Site
Bellshill, Lanarkshire, ML4 3NJ, United Kingdom
-
Clinical Trial Site
Carshalton, United Kingdom
-
Clinical Trial Site
Edinburgh, United Kingdom
-
Clinical Trial Site
Fowey, United Kingdom
-
Clinical Trial Site
Glasgow, United Kingdom
-
Clinical Trial Site
Lancashire Preston, United Kingdom
-
Clinical Trial Site
Liskeard, United Kingdom
-
Clinical Trial Site
London, United Kingdom
-
Clinical Trial Site
Manchester, United Kingdom
-
Clinical Trial Site
Newquay, United Kingdom
-
Clinical Trial Site
Plymouth, United Kingdom
-
Clinical Trial Site
Sheffield, United Kingdom
-
Clinical Trial Site
Torpoint, United Kingdom
-
Clinical Trial site
Winston-Salem, North Carolina, 27157, United States
-
Clinical Trials Site
Beverly Hills, California, 90211, United States
Conditions
Explore the condition pages connected to this study.